PremiumRatingsAlignment Healthcare’s Strong Q1 2025 Performance and Positive Outlook Justify Buy Rating Alignment Healthcare sees Q2 revenue $950M-$965M, consensus $945.89M Alignment Healthcare raises FY25 revenue view to $3.77B-$3.82B from $3.72B-$3.78 PremiumThe FlyAlignment Healthcare price target raised to $22 from $17 at Baird Morning Movers: Stock futures rebound following days of dips Alignment Healthcare price target raised to $23 from $18 at Stifel PremiumCompany AnnouncementsAlignment Healthcare Reports Strong Growth in Earnings Call Alignment Healthcare: Strong Buy Rating Driven by Operational Efficiency and Promising Growth Outlook Alignment Healthcare price target raised to $18 from $16 at Stifel